TD Private Client Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Buy
133,648
+7,887
+6% +$636K 0.19% 77
2026
Q1
$10.9M Buy
125,761
+17,594
+16% +$1.69M 0.23% 66
2025
Q4
$10.4M Buy
108,167
+1,893
+2% +$184K 0.22% 70
2025
Q3
$10.1M Sell
106,274
-11,652
-10% -$1.07M 0.23% 69
2025
Q2
$10.3M Buy
117,926
+19,501
+20% +$1.65M 0.25% 65
2025
Q1
$8.84M Buy
98,425
+40,151
+69% +$3.59M 0.24% 68
2024
Q4
$4.65M Sell
58,274
-2,786
-5% -$241K 0.13% 121
2024
Q3
$5.5M Buy
61,060
+2,782
+5% +$234K 0.16% 97
2024
Q2
$4.59M Sell
58,278
-1,227
-2% -$101K 0.14% 109
2024
Q1
$5.19M Sell
59,505
-20,962
-26% -$1.79M 0.17% 94
2023
Q4
$6.63M Sell
80,467
-22,660
-22% -$1.73M 0.24% 70
2023
Q3
$8.08M Buy
103,127
+1,695
+2% +$142K 0.35% 51
2023
Q2
$8.94M Sell
101,432
-3,331
-3% -$287K 0.39% 47
2023
Q1
$8.45M Buy
104,763
+6,670
+7% +$544K 0.38% 44
2022
Q4
$7.62M Buy
98,093
+18,073
+23% +$1.46M 0.36% 51
2022
Q3
$6.46M Buy
80,020
+4,041
+5% +$363K 0.33% 58
2022
Q2
$6.82M Sell
75,979
-753
-1% -$76.3K 0.33% 62
2022
Q1
$8.51M Buy
76,732
+2,347
+3% +$248K 0.36% 56
2021
Q4
$7.7M Sell
74,385
-103
-0.1% -$11.9K 0.32% 63
2021
Q3
$9.34M Buy
74,488
+1,286
+2% +$166K 0.4% 51
2021
Q2
$9.09M Buy
73,202
+2,045
+3% +$257K 0.39% 53
2021
Q1
$8.41M Sell
71,157
-326
-0.5% -$38.2K 0.39% 53
2020
Q4
$8.37M Sell
71,483
-1,045
-1% -$115K 0.42% 50
2020
Q3
$7.54M Sell
72,528
-3,177
-4% -$319K 0.42% 54
2020
Q2
$6.94M Buy
75,705
+368
+0.5% +$35.3K 0.41% 59
2020
Q1
$6.79M Buy
75,337
+1,381
+2% +$147K 0.49% 50
2019
Q4
$8.39M Buy
+73,956
New +$8.12M 0.5% 48

Other funds holding MDT

TD Private Client Wealth's MDT Position: Q2 2026 in Review

TD Private Client Wealth increased its Medtronic (MDT) stake by 6.3% in Q2 2026, buying an estimated $636K and bringing the position to 133,648 shares worth $10.5M. The position accounts for 0.19% of the portfolio, ranked #77.

TD Private Client Wealth first reported a position in MDT in Q4 2019 and has held it in 27 quarters since. The position peaked at $10.9M in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • TD Private Client Wealth held 133,648 shares of Medtronic worth $10.5M as of Q2 2026.
  • TD Private Client Wealth bought 7,887 Medtronic shares in Q2 2026, an estimated $636K.
  • Medtronic made up 0.19% of TD Private Client Wealth's portfolio in Q2 2026, its #77 holding.
  • TD Private Client Wealth first reported a position in Medtronic in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's Medtronic position peaked at $10.9M in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.